Genomic Medicine

Medicine & Life Sciences

1. Neoplasms 100%
2. Melanoma 51%
3. Mutation 50%
4. Genes 37%
5. Genome 36%
6. Glioblastoma 28%
7. Microbiota 26%
8. Therapeutics 24%
9. Adenocarcinoma 23%
10. T-Lymphocytes 22%
11. Proteins 19%
12. Neoplasm Metastasis 17%
13. Telomere 17%
14. Epigenomics 17%
15. Atlases 17%
16. Carcinogenesis 16%
17. Gastrointestinal Microbiome 15%
18. Pancreatic Neoplasms 15%
19. Glioma 15%
20. Adenocarcinoma of Lung 15%
21. Gene Expression 14%
22. Survival 14%
23. Acute Myeloid Leukemia 13%
24. Oncogenes 13%
25. Growth 13%
26. Breast Neoplasms 13%
27. Ovarian Neoplasms 13%
28. Neoplasm Genes 13%
29. Chromatin 13%
30. Phenotype 12%
31. Immunotherapy 12%
32. Telomerase 12%
33. Apoptosis 12%
34. DNA 11%
35. Cell Line 11%
36. MicroRNAs 11%
37. Stem Cells 11%
38. DNA Methylation 11%
39. Colorectal Neoplasms 10%
40. Lung Neoplasms 10%
41. Non-Small Cell Lung Carcinoma 10%
42. Genomics 10%
43. Tumor Microenvironment 9%
44. Methylation 9%
45. Renal Cell Carcinoma 9%
46. Prostatic Neoplasms 9%
47. Histones 9%
48. Graft vs Host Disease 9%
49. Biomarkers 9%
50. Leukemia 8%
51. Whole Genome Sequencing 8%
52. Multiple Myeloma 8%
53. DNA Damage 8%
54. Maintenance 8%
55. Dendritic Cells 8%
56. Mitogen-Activated Protein Kinase Kinases 8%
57. Phosphotransferases 8%
58. Arabidopsis 7%
59. Heterografts 7%
60. Cell Cycle 7%
61. Ligands 7%
62. Lung 7%
63. Oxidative Phosphorylation 7%
64. RNA Sequence Analysis 7%
65. Mantle-Cell Lymphoma 7%
66. Drug Therapy 7%
67. Myelodysplastic Syndromes 7%
68. Datasets 7%
69. Whole Exome Sequencing 7%
70. In Vitro Techniques 7%
71. T-Cell Antigen Receptor 7%
72. Recurrence 7%
73. Transcription Factors 7%
74. Epithelial-Mesenchymal Transition 7%
75. Pharmaceutical Preparations 7%
76. Messenger RNA 7%
77. Circulating Tumor DNA 6%
78. Transcriptome 6%
79. Immunity 6%
80. Colonic Neoplasms 6%
81. Fecal Microbiota Transplantation 6%
82. Melanocytes 6%
83. Exome 6%
84. 4-hydroxy-2-nonenal 6%
85. Allogeneic Cells 6%
86. B-Lymphocytes 6%
87. Phosphatidylinositol 3-Kinases 6%
88. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6%
89. Cell Proliferation 6%
90. High-Throughput Nucleotide Sequencing 6%
91. RNA 6%
92. Tumor Suppressor Genes 6%
93. Up-Regulation 6%
94. Uterine Cervical Neoplasms 6%
95. Neoplastic Stem Cells 5%
96. Drug Discovery 5%
97. Chromosomes 5%
98. Adenoid Cystic Carcinoma 5%
99. ErbB Receptors 5%
100. Protein Array Analysis 5%